Dr. Barry Dworkin

Pfizer vaccine recipients have lower neutralizing antibodies targeting delta variant up to three months after first dose. Outcome data needed to determine if this translates into less efficacy. Study concludes second dose interval needs to be shortened.

Medical Mythbusting Commentary for June 4, 2021

[display_podcast]

Source:
Pfizer vaccine recipients have lower antibodies targeting Indian variant – study
Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant

Reference:
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Related posts:

  1. Los Alamos Lab uses computational analysis of 6000 coronavirus sequences to conclude that a mutated strain is now dominant. Clinical implications remain unknown and study needs to be peer -reviewed and published.
  2. Unmasking the untruths
  3. Up, up, and away! …….again
  4. More robust contact tracing site identification required to determine where COVID-19 infections are more likely to occur.